Point72 Asset Management L.P. Invests $27.43 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Point72 Asset Management L.P. bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 1,492,299 shares of the company's stock, valued at approximately $27,428,000. Point72 Asset Management L.P. owned 1.05% of Ardent Health Partners at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Goldentree Asset Management LP acquired a new position in Ardent Health Partners during the third quarter worth about $22,897,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $13,119,000. Seven Grand Managers LLC acquired a new stake in Ardent Health Partners in the third quarter valued at $2,298,000. Charles Schwab Investment Management Inc. purchased a new position in Ardent Health Partners during the 3rd quarter valued at about $526,000. Finally, Centiva Capital LP purchased a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $469,000.

Ardent Health Partners Price Performance

Ardent Health Partners stock traded up $0.65 during midday trading on Friday, reaching $16.65. The stock had a trading volume of 282,704 shares, compared to its average volume of 350,352. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The firm has a 50-day moving average price of $17.58. Ardent Health Partners, LLC has a twelve month low of $14.57 and a twelve month high of $20.72.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Royal Bank of Canada restated an "outperform" rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Morgan Stanley started coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an "overweight" rating and a $27.00 price target on the stock. Leerink Partners lifted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. Citigroup began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a "buy" rating and a $21.00 price objective on the stock. Finally, KeyCorp started coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They issued an "overweight" rating and a $24.00 target price for the company. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $21.82.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.